|
[20] Processing of X-ray diffraction data collected in oscillation mode
|
book
|
January 1997 |
|
Unraveling hot spots in binding interfaces: progress and challenges
|
journal
|
February 2002 |
|
The “Clonal Selection Hypothesis” and Current Concepts of B Cell Tolerance
|
journal
|
September 1996 |
|
Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: Implications for evasion of immune responses and design of vaccine immunogens
|
journal
|
December 2009 |
|
Germinal Center Dynamics Revealed by Multiphoton Microscopy with a Photoactivatable Fluorescent Reporter
|
journal
|
November 2010 |
|
Somatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 Neutralization
|
journal
|
March 2013 |
|
Structural Insights on the Role of Antibodies in HIV-1 Vaccine and Therapy
|
journal
|
February 2014 |
|
Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors
|
journal
|
June 2015 |
|
Immunization for HIV-1 Broadly Neutralizing Antibodies in Human Ig Knockin Mice
|
journal
|
June 2015 |
|
Sequential Immunization Elicits Broadly Neutralizing Anti-HIV-1 Antibodies in Ig Knockin Mice
|
journal
|
September 2016 |
|
Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico
|
journal
|
May 2017 |
|
Antibody 27F3 Broadly Targets Influenza A Group 1 and 2 Hemagglutinins through a Further Variation in V H 1-69 Antibody Orientation on the HA Stem
|
journal
|
September 2017 |
|
Identification of Anergic B Cells within a Wild-Type Repertoire
|
journal
|
December 2006 |
|
Germinal-Center Organization and Cellular Dynamics
|
journal
|
August 2007 |
|
Bcl6 Protein Expression Shapes Pre-Germinal Center B Cell Dynamics and Follicular Helper T Cell Heterogeneity
|
journal
|
June 2011 |
|
Identification of Common Features in Prototype Broadly Neutralizing Antibodies to HIV Envelope V2 Apex to Facilitate Vaccine Design
|
journal
|
November 2015 |
|
HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies
|
journal
|
September 2016 |
|
Precursor Frequency and Affinity Determine B Cell Competitive Fitness in Germinal Centers, Tested with Germline-Targeting HIV Vaccine Immunogens
|
journal
|
January 2018 |
|
Infants Infected with Respiratory Syncytial Virus Generate Potent Neutralizing Antibodies that Lack Somatic Hypermutation
|
journal
|
February 2018 |
|
An Antibody Targeting the Fusion Machinery Neutralizes Dual-Tropic Infection and Defines a Site of Vulnerability on Epstein-Barr Virus
|
journal
|
April 2018 |
|
HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure
|
journal
|
May 2018 |
|
Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning
|
journal
|
January 2008 |
|
Cloning and expression of murine Ig genes from single B cells
|
journal
|
October 2009 |
|
Arranged Sevenfold: Structural Insights into the C-Terminal Oligomerization Domain of Human C4b-Binding Protein
|
journal
|
April 2013 |
|
Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice
|
journal
|
August 1988 |
|
Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire
|
journal
|
September 1994 |
|
Neutralizing antibody directed against the HIV–1 envelope glycoprotein can completely block HIV–1/SIV chimeric virus infections of macaque monkeys
|
journal
|
February 1999 |
|
Structural definition of a conserved neutralization epitope on HIV-1 gp120
|
journal
|
February 2007 |
|
Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals
|
journal
|
March 2009 |
|
Broad neutralization coverage of HIV by multiple highly potent antibodies
|
journal
|
September 2011 |
|
Broad and potent neutralization of HIV-1 by a gp41-specific human antibody
|
journal
|
September 2012 |
|
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
|
journal
|
April 2013 |
|
Broad and potent HIV-1 neutralization by a human antibody that binds the gp41–gp120 interface
|
journal
|
September 2014 |
|
Structure and immune recognition of trimeric pre-fusion HIV-1 Env
|
journal
|
October 2014 |
|
A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges
|
journal
|
April 2016 |
|
B-cell–lineage immunogen design in vaccine development with HIV-1 as a case study
|
journal
|
May 2012 |
|
Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice
|
journal
|
February 2016 |
|
Efficient generation of monoclonal antibodies against peptide in the context of MHCII using magnetic enrichment
|
journal
|
June 2016 |
|
IgD attenuates the IgM-induced anergy response in transitional and mature B cells
|
journal
|
November 2016 |
|
Control systems and decision making for antibody production
|
journal
|
July 2010 |
|
HIV vaccine design and the neutralizing antibody problem
|
journal
|
March 2004 |
|
Vectored immunoprophylaxis protects humanized mice from mucosal HIV transmission
|
journal
|
February 2014 |
|
Determinants of HIV-1 broadly neutralizing antibody induction
|
journal
|
September 2016 |
|
Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know
|
journal
|
August 2004 |
|
Mechanisms of central tolerance for B cells
|
journal
|
April 2017 |
|
Receptor editing in lymphocyte development and central tolerance
|
journal
|
October 2006 |
|
Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning
|
journal
|
August 2013 |
|
Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses
|
journal
|
February 2009 |
|
Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design
|
journal
|
December 2015 |
|
Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies
|
journal
|
March 2019 |
|
Passive Transfer of A Germline-like Neutralizing Human Monoclonal Antibody Protects Transgenic Mice Against Lethal Middle East Respiratory Syndrome Coronavirus Infection
|
journal
|
August 2016 |
|
Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies
|
journal
|
April 2008 |
|
Autoreactivity in an HIV-1 broadly reactive neutralizing antibody variable region heavy chain induces immunologic tolerance
|
journal
|
December 2009 |
|
Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention
|
journal
|
February 2012 |
|
A mouse model for HIV-1 entry
|
journal
|
September 2012 |
|
Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo
|
journal
|
October 2012 |
|
Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies
|
journal
|
October 2012 |
|
Large-scale sequence and structural comparisons of human naive and antigen-experienced antibody repertoires
|
journal
|
April 2016 |
|
A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals.
|
journal
|
November 1991 |
|
Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro.
|
journal
|
October 1992 |
|
Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: Clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant
|
journal
|
December 1997 |
|
An inverse relationship between T cell receptor affinity and antigen dose during CD4+ T cell responses in vivo and in vitro
|
journal
|
August 1999 |
|
Reduced life span of anergic self-reactive B cells in a double- transgenic model
|
journal
|
January 1994 |
|
Immunoglobulin signal transduction guides the specificity of B cell-T cell interactions and is blocked in tolerant self-reactive B cells
|
journal
|
February 1994 |
|
Deletion and anergy of polyclonal B cells specific for ubiquitous membrane-bound self-antigen
|
journal
|
October 2012 |
|
Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies
|
journal
|
March 2013 |
|
Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques
|
journal
|
August 2014 |
|
Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design
|
journal
|
March 2016 |
|
Development of a Humanized Monoclonal Antibody (MEDI‐493) with Potent In Vitro and In Vivo Activity against Respiratory Syncytial Virus
|
journal
|
November 1997 |
|
Daedalus: a robust, turnkey platform for rapid production of decigram quantities of active recombinant proteins in human cell lines using novel lentiviral vectors
|
journal
|
September 2011 |
|
Coot model-building tools for molecular graphics
|
journal
|
November 2004 |
|
PHENIX: a comprehensive Python-based system for macromolecular structure solution
|
journal
|
January 2010 |
|
The CCP4 suite programs for protein crystallography
|
journal
|
September 1994 |
|
Transitional B cell subsets in human bone marrow: Transitional B cell subsets in human bone marrow
|
journal
|
September 2013 |
|
HIV-1 neutralizing antibodies: understanding nature's pathways
|
journal
|
June 2013 |
|
T cells and follicular dendritic cells in germinal center B-cell formation and selection: Roles of T cells and FDCs in germinal centers
|
journal
|
August 2010 |
|
Unique properties of memory B cells of different isotypes: Memory B cells of different isotypes
|
journal
|
August 2010 |
|
Cardiolipin Polyspecific Autoreactivity in Two Broadly Neutralizing HIV-1 Antibodies
|
journal
|
June 2005 |
|
Antibody Recognition of a Highly Conserved Influenza Virus Epitope
|
journal
|
April 2009 |
|
Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
|
journal
|
September 2009 |
|
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
|
journal
|
July 2010 |
|
Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01
|
journal
|
July 2010 |
|
A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses
|
journal
|
July 2011 |
|
A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins
|
journal
|
July 2011 |
|
Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding
|
journal
|
July 2011 |
|
Highly Conserved Protective Epitopes on Influenza B Viruses
|
journal
|
August 2012 |
|
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
|
journal
|
March 2013 |
|
Antibodies in HIV-1 Vaccine Development and Therapy
|
journal
|
September 2013 |
|
Antigen modification regulates competition of broad and narrow neutralizing HIV antibodies
|
journal
|
December 2014 |
|
Apoptosis and antigen affinity limit effector cell differentiation of a single naive B cell
|
journal
|
January 2015 |
|
Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen
|
journal
|
June 2015 |
|
HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen
|
journal
|
March 2016 |
|
Antibody-mediated protection against SHIV challenge includes systemic clearance of distal virus
|
journal
|
August 2016 |
|
Prefusion F–specific antibodies determine the magnitude of RSV neutralizing activity in human sera
|
journal
|
October 2015 |
|
Immune history profoundly affects broadly protective B cell responses to influenza
|
journal
|
December 2015 |
|
Initiation of immune tolerance–controlled HIV gp41 neutralizing B cell lineages
|
journal
|
April 2016 |
|
The Oligomerization Domain of C4-Binding Protein (C4bp) Acts as an Adjuvant, and the Fusion Protein Comprised of the 19-Kilodalton Merozoite Surface Protein 1 Fused with the Murine C4bp Domain Protects Mice against Malaria
|
journal
|
May 2008 |
|
Antibody and Antiretroviral Preexposure Prophylaxis Prevent Cervicovaginal HIV-1 Infection in a Transgenic Mouse Model
|
journal
|
May 2013 |
|
HIV-1 Subtype C-Infected Children with Exceptional Neutralization Breadth Exhibit Polyclonal Responses Targeting Known Epitopes
|
journal
|
June 2018 |
|
Crystal Structure of PG16 and Chimeric Dissection with Somatically Related PG9: Structure-Function Analysis of Two Quaternary-Specific Antibodies That Effectively Neutralize HIV-1
|
journal
|
June 2010 |
|
Structure of a Classical Broadly Neutralizing Stem Antibody in Complex with a Pandemic H2 Influenza Virus Hemagglutinin
|
journal
|
April 2013 |
|
Diverse Recombinant HIV-1 Envs Fail To Activate B Cells Expressing the Germline B Cell Receptors of the Broadly Neutralizing Anti-HIV-1 Antibodies PG9 and 447-52D
|
journal
|
December 2013 |
|
Protection of Macaques against Pathogenic Simian/Human Immunodeficiency Virus 89.6PD by Passive Transfer of Neutralizing Antibodies
|
journal
|
January 1999 |
|
Antibody Protects Macaques against Vaginal Challenge with a Pathogenic R5 Simian/Human Immunodeficiency Virus at Serum Levels Giving Complete Neutralization In Vitro
|
journal
|
September 2001 |
|
The Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2G12 Recognizes a Cluster of 1->2 Mannose Residues on the Outer Face of gp120
|
journal
|
July 2002 |
|
Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion function.
|
journal
|
January 1989 |
|
A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains.
|
journal
|
January 1993 |
|
Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design
|
journal
|
May 2016 |
|
Novel HIV vaccine strategies: overview and perspective
|
journal
|
July 2013 |
|
Development of prophylactic vaccines against HIV-1
|
journal
|
January 2013 |
|
Heterosubtypic Neutralizing Monoclonal Antibodies Cross-Protective against H5N1 and H1N1 Recovered from Human IgM+ Memory B Cells
|
journal
|
December 2008 |
|
Broadly Neutralizing Human Anti-HIV Antibody 2G12 Is Effective in Protection against Mucosal SHIV Challenge Even at Low Serum Neutralizing Titers
|
journal
|
May 2009 |
|
Recombinant HIV Envelope Proteins Fail to Engage Germline Versions of Anti-CD4bs bNAbs
|
journal
|
January 2013 |
|
Broadly Neutralizing Antibody Responses in a Large Longitudinal Sub-Saharan HIV Primary Infection Cohort
|
journal
|
January 2016 |
|
B Cells from Knock-in Mice Expressing Broadly Neutralizing HIV Antibody b12 Carry an Innocuous B Cell Receptor Responsive to HIV Vaccine Candidates
|
journal
|
August 2013 |
|
Immune Tolerance Negatively Regulates B Cells in Knock-In Mice Expressing Broadly Neutralizing HIV Antibody 4E10
|
journal
|
August 2013 |
|
Cutting Edge: Introduction of an Endopeptidase Cleavage Motif into a Determinant Flanking Region of Hen Egg Lysozyme Results in Enhanced T Cell Determinant Display
|
journal
|
July 2000 |
|
Resolution of Three Nonproliferative Immature Splenic B Cell Subsets Reveals Multiple Selection Points During Peripheral B Cell Maturation
|
journal
|
December 2001 |
|
Therapeutic antibodies, vaccines and antibodyomes
|
journal
|
May 2010 |